Amniotic fluid stem cells in a bone microenvironment: Driving host angiogenic response

Teodelinda Mirabella, Chiara Gentili, Antonio Daga, Ranieri Cancedda

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The repair of skeletal defects remains a substantial economic and biomedical burden. The extra-embryonic fetal stem cells derived from amniotic fluid (AFSCs) have been used for the treatment of large bone defects, but mechanisms of repair are not clear. Here we studied the potential contribution of human AFSCs to the modeling of an ectopic bone.We found that AFSCs are not osteogenic in vivo, and, compared to bone marrow-derived stromal cells, recruit more host CD31 and VEGF-R2 positive cells. Finally, when AFSCs were co-implanted with human-bone forming cells, a normo-osteosynthesis occurred, the engineered ossicle was hyper-vascularized, but AFSCs were not retrieved in the implant within 2weeks. We concluded that AFSCs do not contribute to the deposition of new bone, but act as a powerful proinflammatory/proangiogenic boost, driving a host response, ending in AFSC clearance and vascularization of the bone environment.In our model, a source of osteocommitted cells, capable to engraft and proliferate in vivo, is needed in order to engineer bone. The angio-attractant properties of AFSCs could be exploited in strategies of endogenous cell homing to actively recruit host progenitors into a predefined anatomic location for in situ bone tissue regeneration.

Original languageEnglish
Pages (from-to)540-551
Number of pages12
JournalStem Cell Research
Volume11
Issue number1
DOIs
Publication statusPublished - Jul 2013

Fingerprint

Amniotic Fluid
Stem Cells
Bone and Bones
Fetal Stem Cells
Bone Regeneration
Embryonic Stem Cells
Mesenchymal Stromal Cells
Vascular Endothelial Growth Factor A
Economics

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology
  • Medicine(all)

Cite this

Amniotic fluid stem cells in a bone microenvironment : Driving host angiogenic response. / Mirabella, Teodelinda; Gentili, Chiara; Daga, Antonio; Cancedda, Ranieri.

In: Stem Cell Research, Vol. 11, No. 1, 07.2013, p. 540-551.

Research output: Contribution to journalArticle

Mirabella, Teodelinda ; Gentili, Chiara ; Daga, Antonio ; Cancedda, Ranieri. / Amniotic fluid stem cells in a bone microenvironment : Driving host angiogenic response. In: Stem Cell Research. 2013 ; Vol. 11, No. 1. pp. 540-551.
@article{8f5001b66be840069f63192881b8f0c3,
title = "Amniotic fluid stem cells in a bone microenvironment: Driving host angiogenic response",
abstract = "The repair of skeletal defects remains a substantial economic and biomedical burden. The extra-embryonic fetal stem cells derived from amniotic fluid (AFSCs) have been used for the treatment of large bone defects, but mechanisms of repair are not clear. Here we studied the potential contribution of human AFSCs to the modeling of an ectopic bone.We found that AFSCs are not osteogenic in vivo, and, compared to bone marrow-derived stromal cells, recruit more host CD31 and VEGF-R2 positive cells. Finally, when AFSCs were co-implanted with human-bone forming cells, a normo-osteosynthesis occurred, the engineered ossicle was hyper-vascularized, but AFSCs were not retrieved in the implant within 2weeks. We concluded that AFSCs do not contribute to the deposition of new bone, but act as a powerful proinflammatory/proangiogenic boost, driving a host response, ending in AFSC clearance and vascularization of the bone environment.In our model, a source of osteocommitted cells, capable to engraft and proliferate in vivo, is needed in order to engineer bone. The angio-attractant properties of AFSCs could be exploited in strategies of endogenous cell homing to actively recruit host progenitors into a predefined anatomic location for in situ bone tissue regeneration.",
author = "Teodelinda Mirabella and Chiara Gentili and Antonio Daga and Ranieri Cancedda",
year = "2013",
month = "7",
doi = "10.1016/j.scr.2013.02.006",
language = "English",
volume = "11",
pages = "540--551",
journal = "Stem Cell Research",
issn = "1873-5061",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Amniotic fluid stem cells in a bone microenvironment

T2 - Driving host angiogenic response

AU - Mirabella, Teodelinda

AU - Gentili, Chiara

AU - Daga, Antonio

AU - Cancedda, Ranieri

PY - 2013/7

Y1 - 2013/7

N2 - The repair of skeletal defects remains a substantial economic and biomedical burden. The extra-embryonic fetal stem cells derived from amniotic fluid (AFSCs) have been used for the treatment of large bone defects, but mechanisms of repair are not clear. Here we studied the potential contribution of human AFSCs to the modeling of an ectopic bone.We found that AFSCs are not osteogenic in vivo, and, compared to bone marrow-derived stromal cells, recruit more host CD31 and VEGF-R2 positive cells. Finally, when AFSCs were co-implanted with human-bone forming cells, a normo-osteosynthesis occurred, the engineered ossicle was hyper-vascularized, but AFSCs were not retrieved in the implant within 2weeks. We concluded that AFSCs do not contribute to the deposition of new bone, but act as a powerful proinflammatory/proangiogenic boost, driving a host response, ending in AFSC clearance and vascularization of the bone environment.In our model, a source of osteocommitted cells, capable to engraft and proliferate in vivo, is needed in order to engineer bone. The angio-attractant properties of AFSCs could be exploited in strategies of endogenous cell homing to actively recruit host progenitors into a predefined anatomic location for in situ bone tissue regeneration.

AB - The repair of skeletal defects remains a substantial economic and biomedical burden. The extra-embryonic fetal stem cells derived from amniotic fluid (AFSCs) have been used for the treatment of large bone defects, but mechanisms of repair are not clear. Here we studied the potential contribution of human AFSCs to the modeling of an ectopic bone.We found that AFSCs are not osteogenic in vivo, and, compared to bone marrow-derived stromal cells, recruit more host CD31 and VEGF-R2 positive cells. Finally, when AFSCs were co-implanted with human-bone forming cells, a normo-osteosynthesis occurred, the engineered ossicle was hyper-vascularized, but AFSCs were not retrieved in the implant within 2weeks. We concluded that AFSCs do not contribute to the deposition of new bone, but act as a powerful proinflammatory/proangiogenic boost, driving a host response, ending in AFSC clearance and vascularization of the bone environment.In our model, a source of osteocommitted cells, capable to engraft and proliferate in vivo, is needed in order to engineer bone. The angio-attractant properties of AFSCs could be exploited in strategies of endogenous cell homing to actively recruit host progenitors into a predefined anatomic location for in situ bone tissue regeneration.

UR - http://www.scopus.com/inward/record.url?scp=84876326773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876326773&partnerID=8YFLogxK

U2 - 10.1016/j.scr.2013.02.006

DO - 10.1016/j.scr.2013.02.006

M3 - Article

C2 - 23584083

AN - SCOPUS:84876326773

VL - 11

SP - 540

EP - 551

JO - Stem Cell Research

JF - Stem Cell Research

SN - 1873-5061

IS - 1

ER -